Skip to content

iDose® TR Patient Savings Program

Section

Patient Savings Program Eligible commercially insured patients may pay as little as $0* for iDose TR.

Savings Program Eligibility Requirements:

  • Have commercial insurance coverage
  • Live in the United States, including US territories
  • Age 18 or older on the date of the iDose TR procedure
  • Receive the iDose TR as prescribed by a US iDose TR-trained physician in alignment with the iDose TR FDA-approved indication
  • Have an out-of-pocket responsibility for iDose TR identified on the insurance plan’s remittance or Explanation of Benefits
  • Have iDose TR procedure on or before December 31, 2025. The program application and Explanation of Benefits must be submitted within 180 days of the procedure date
  • Have the Explanation of Benefits from your iDose TR procedure available from your insurance plan. It is required to complete this application

Note: You need your Explanation of Benefits (EOB) from your insurance company to submit this application.

*Eligibility criteria apply. Offer valid only for commercially insured patients with a plan covering iDose TR; patient out-of-pocket expense may vary. This offer applies to the iDose TR implant only and does not apply to costs for any other medication, procedure, or diagnostic service provided in conjunction or supportive to the iDose TR treatment. Offer not valid for patients receiving reimbursement from Medicare, Medicaid, or any other federal, state, or government-funded healthcare program.

Do you have questions about this program?

Call (888) 441-2519 or email iDoseTRpatientservices@glaukos.com.

Terms & Conditions

Eligibility Check

We’re sorry. You do not appear to be eligible for the iDose TR Patient Co-pay Program according to the requirements listed below.

If you believe you are eligible or incorrect information was entered, complete the application form again. You can also call for help at (888) 441-2519 or email iDoseTRpatientservices@glaukos.com.

Savings Program Eligibility Requirements:

  • Have commercial insurance coverage
  • Live in the United States, including US Territories
  • Age 18 or older on the date of the iDose TR procedure
  • Receive the iDose TR as prescribed by a US iDose TR-trained physician in alignment with the iDose TR FDA-approved indication
  • Have an out-of-pocket responsibility for iDose TR identified on the insurance plan’s remittance or Explanation of Benefits
  • Have iDose TR procedure on or before December 31, 2025. The program application and Explanation of Benefits must be submitted within 180 days of the procedure date
  • Have the Explanation of Benefits from your iDose TR procedure available from your insurance plan. It is required to complete this application

Thank You!

Thank you for submitting your application. We have received your information. Please allow 6-8 weeks for processing. If you have questions, contact Glaukos Patient Services (GPS) at (888) 441-2519 or email iDoseTRpatientservices@glaukos.com.

Important Safety Information

iDose TR is gently placed directly inside your eye by your eye doctor.

You should not have iDose TR if you have an infection or suspected infection in your eye or the area surrounding your eye, have corneal endothelial cell dystrophy, a condition in which the clear front layer of your eye (cornea) has lost its ability to work normally as this can cause vision problems, have had a corneal transplant or cells transplanted to the inner layer of the cornea (endothelial cell transplant), are allergic to any of its ingredients, and/or have narrow angles (the iris and the cornea are too close together).

The most common side effect of iDose TR was increased eye pressure. Other common side effects were inflammation of the iris, dry eye, a loss of part of the usual field of vision, eye pain, eye redness and reduced clearness of vision.

If you have additional questions, please contact your doctor. For full Prescribing Information click here.

Approved Uses

iDose TR (travoprost intracameral implant) is a prescription medicine and drug delivery system for the eye approved to lower eye pressure in patients with open-angle glaucoma or high eye pressure (ocular hypertension).

You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also call Glaukos at 1-888-404-1644.